POCK model simulations of pulmonary quartz dust retention data in extended inhalation exposures of rats

Luminescence Studies and Judd-Ofelt Analysis on SiO2@LaPO4:Eu@SiO2 Submicro-spheres with Different Size of Intermediate Shells

The novel submicro-spheres SiO₂@LaPO₄:Eu@SiO₂ with core-shell-shell structures were prepared by connecting the SiO₂ submicro-spheres and the rare earth ions through an organosilane HOOCC₆H₄N(CONH(CH₂)₃Si(OCH₂CH₃)₃ (MABA-Si). The as-prepared products were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), and infrared spectroscopy (IR). It is found that the intermediate shell of the submicro-spheres was composed by LaPO₄:Eu nanoparticles with the size of about 4, 5-7, or 15-34 nm. A possible formation mechanism for the SiO₂@LaPO₄:Eu@SiO₂ submicro-spheres has been proposed. The dependence of the photoluminescence intensity on the size of the LaPO₄:Eu nanoparticles has been investigated. The intensity ratios of electrical dipole transition ⁵D₀ → ⁷F₂ to magnetic dipole transition ⁵D₀ → ⁷F₁ of Eu³⁺ ions were increased with decreasing the size of LaPO₄:Eu nanoparticles. According to the Judd-Ofelt (J-O) theory, when the size of LaPO₄:Eu nanoparticles was about 4, 5-7 and 15-34 nm, the calculated J-O parameter Ω₂ (optical transition intensity parameter) was 2.30 × 10^-20, 1.80 × 10^-20 and 1.20 × 10^-20, respectively. The increase of Ω₂ indicates that the symmetry of Eu³⁺ in the LaPO₄ lattice was gradually reduced. The photoluminescence intensity of the SiO₂@LaPO₄:Eu@SiO₂ submicro-spheres was unquenched in aqueous solution even after 15 days.

Consequent stages of developing a multi-compartmental mechanistic model for chronically inhaled nanoparticles pulmonary retention

•

A mechanistic model of inhaled particle pulmonary retention is adjusted to describe that of nanoparticles (NP).

•

Its stucture and parameters were verified based on experiments with NPs of Fe₂O₃, SiO₂ and NiO.

•

Unlike modeling mineral dusts retention, for nano-aerosols it proved necessary to describe NP solubilization .

•

Under chronic inhalation exposure, a damage to clearance mechanisms makes adjust the model.

The paper retraces the development of a mechanistic multicompartmental system model describing particle retention in lungs under chronic inhalation exposures. This model was first developed and experimentally tested for various conditions of exposure to polydisperse dusts of SiO₂ or TiO₂. Later on it was successfully used as a basis for analyzing patterns in the retention of nanoparticles having different chemical compositions (Fe₂O₃, SiO₂, NiO). This is the first publication presenting the outcomes of modeling lung retention of nickel oxide nano-aerosols under chronic inhalation exposure.

The most significant adaptation of the above-mentioned model to the conditions of exposure to metal-oxide nanoparticles is associated with the need to describe mathematically not only the physiological mechanisms of their elimination but also their solubilization “in vivo” bearing in mind that the relative contribution of the latter may be different for nanoparticles of different nature and predominant in some cases.

Using nickel oxide as an example, it is suggested as well that damage to the physiological pulmonary clearance mechanisms by particularly toxic nanoparticles may result in lung toxicokinetics becoming nonlinear.

Synthesis and photoluminescence properties of novel core–shell–shell SiO2@CePO4:Tb@SiO2 submicro-spheres

The low-cost preparation of the core–shell–shell SiO₂@CePO₄:Tb@SiO₂ was achieved, and the biocompatibility was improved with the use of SiO₂.

Controlled synthesis of EuPO4 nano/microstructures and core–shell SiO2@EuPO4 nanostructures with improved photoluminescence

EuPO₄ nanoparticles coated on SiO₂ submicro-spheres not only improve the photoluminescence properties but also change the symmetry of the Eu³⁺ ions.

Dose-dependent clearance kinetics of intratracheally administered titanium dioxide nanoparticles in rat lung

AEROSIL(®) P25 titanium dioxide (TiO2) nanoparticles dispersed in 0.2% disodium phosphate solution were intratracheally administered to male F344 rats at doses of 0 (control), 0.375, 0.75, 1.5, 3.0, and 6.0 mg/kg. The rats were sacrificed under anesthesia at 1 day, 3 days, 7 days, 4 weeks, 13 weeks, and 26 weeks after administration. Ti levels in various pulmonary and extrapulmonary organs were determined using sensitive inductively coupled plasma sector field mass spectrometry. One day after administration, the lungs contained 62-83% of TiO2 administered dose. Twenty-six weeks after administration, the lungs retained 6.6-8.9% of the TiO2 administered at the 0.375, 0.75, and 1.5 mg/kg doses, and 13% and 31% of the TiO2 administered at the 3.0 and 6.0 mg/kg doses, respectively. The pulmonary clearance rate constants from compartment 1, k1, were estimated using a 2-compartment model and were found to be higher for the 0.375 and 0.75 mg/kg doses of TiO2 (0.030/day for both) than for TiO2 doses of 1.5-6.0 mg/kg (0.014-0.022/day). The translocation rate constants from compartment 1 to 2, k12, were estimated to be 0.015 and 0.018/day for the 0.375 and 0.75 mg/kg doses, and 0.0025-0.0092/day for doses of 1.5-6.0mg/kg. The pulmonary clearance rate constants from compartment 2, k2, were estimated to be 0.0086 and 0.0093/day for doses of 0.375 and 0.75 mg/kg, and 0-0.00082/day for 1.5-6.0 mg/kg doses. Translocation of TiO2 from the lungs to the thoracic lymph nodes increased in a time- and dose-dependent manner, accounting for 0.10-3.4% of the administered dose at 26 weeks. The measured thoracic lymph node burdens were a much better fit to the thoracic lymph node burdens estimated assuming translocation from compartment 1 to the thoracic lymph nodes, rather than those estimated assuming translocation from compartment 2 to the thoracic lymph nodes. The translocation rate constants from the lungs to the thoracic lymph nodes, kLung→Lym, were 0.000037-0.00081/day, and these also increased with increasing doses of TiO2. Although a small amount of TiO2 had translocated to the liver by 3 days after the administration (0.0023-0.012% of the highest dose administered, 6.0 mg/kg), translocation to the other extrapulmonary organs was not detected.

Estimation of dissolution rate from in vivo studies of synthetic vitreous fibers

Although the dissolution rate of a fiber was originally defined by a measurement of dissolution in simulated lung fluid in vitro, it is feasible to determine it from animal studies as well. The dissolution rate constant for a fiber may be extracted from the decrease in long fiber diameter observed in certain intratracheal instillation experiments or from the observed long fiber retention in short-term biopersistence studies. These in vivo dissolution rates agree well with those measured in vitro for the same fibers. For those special types of fibers, the high-alumina rock wool fibers that could not be measured in vitro, the method provides a way of obtaining a chemical dissolution rate constant from an animal study. The inverse of the in vivo dissolution rate, the fiber dissolution time, correlates well with the weighted half life of long fibers in a biopersistence study, and the in vivo dissolution rate may be estimated accurately from this weighted half-life.